BlackRock Fund Advisors’s Acura Pharmaceuticals ACUR Stock Holding History

BlackRock Fund Advisors’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8K	Buy	10,515 +2,160	+26%	+$2.26K	﹤0.01%	4000
2016 Q3	$13K	Buy	8,355 +6,535	+359%	+$11.6K	﹤0.01%	3932
2016 Q2	$3K	Buy	1,820 +128	+8%	+$330	﹤0.01%	4201
2016 Q1	$5K	Buy	1,692 +308	+22%	+$655	﹤0.01%	4107
2015 Q4	$3K	Buy	+1,384	New	+$3.37K	﹤0.01%	4267
2015 Q2	–	Sell	-8,522	Closed	-$34K	–	3931
2015 Q1	$34K	Sell	8,522 -579	-6%	-$1.85K	﹤0.01%	3721
2014 Q4	$20K	Buy	9,101 +651	+8%	+$1.8K	﹤0.01%	3708
2014 Q3	$33K	Sell	8,450 -615	-7%	-$2.89K	﹤0.01%	3739
2014 Q2	$49K	Buy	9,065 +259	+3%	+$1.57K	﹤0.01%	3685
2014 Q1	$64K	Buy	8,806 +1,069	+14%	+$9.29K	﹤0.01%	3637
2013 Q4	$65K	Buy	7,737 +324	+4%	+$2.74K	﹤0.01%	3631
2013 Q3	$70K	Buy	7,413 +584	+9%	+$5.16K	﹤0.01%	3590
2013 Q2	$64K	Buy	+6,829	New	+$77.2K	﹤0.01%	3590

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Fund Advisors's ACUR Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Acura Pharmaceuticals (ACUR) stake by 26% in Q4 2016, buying an estimated $2.26K and bringing the position to 10,515 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #4000.

BlackRock Fund Advisors first reported a position in ACUR in Q2 2013 and has held it in 13 quarters since. The position peaked at $70K in Q3 2013. 22 funds tracked by Wall St. Rank hold ACUR as of Q4 2016.

BlackRock Fund Advisors held 10,515 shares of Acura Pharmaceuticals worth $8K as of Q4 2016.
BlackRock Fund Advisors bought 2,160 Acura Pharmaceuticals shares in Q4 2016, an estimated $2.26K.
Acura Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4000 holding.
BlackRock Fund Advisors first reported a position in Acura Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
BlackRock Fund Advisors's Acura Pharmaceuticals position peaked at $70K in Q3 2013.
22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.